Creating miracles, one family at a time: Our passion for reproductive medicine and genetics is fueled by your dreams.

Francisco joined the FutureLife team in April 2023. With over 20 years of experience spanning multiple industries and geographies, including roles at AniCura (Veterinary Health - Europe), GrandVision (Optical retail – 43 countries), Nike (Wholesale / Retail – EMEA), and Banking (LATAM), Francisco excels in leading, mentoring, and inspiring teams to address complex business challenges with a focus on rapid improvement. He thrives in a culture characterized by integrity, inspiration, and curiosity. Francisco holds a Master's degree in Economics from the Universidad de Buenos Aires and an MBA from IAE Business School.

Jane joined FutureLife in September 2023 as Chief Growth Officer, bringing a wealth of expertise in marketing, pricing strategies, and business development. Jane's held various leadership roles at Debenhams. These roles enabled her to successfully demonstrate her ability to develop marketing talent, building high-performing teams, and deliver successful marketing campaigns across multiple media platforms. Her contributions have been recognised with many prestigious awards. These included the World Retail Award for Best Social Media Campaign, a Cannes Lion for an innovative digital Mother’s Day campaign, and most recently an award for a campaign which celebrated women’s health in mid-life. Throughout her career, she has shown a remarkable talent for brand positioning and precise consumer targeting. Collaborating closely with clinical leaders and using consumer insights has been a crucial part of her success.

Ignacio joined FutureLife as Chief Transformation Officer in November 2023, bringing over 20 years of extensive experience in innovation and technology across Europe, the Americas, and the Middle East. Previously, as Managing Director at Seidor, Ignacio lead a comprehensive portfolio of innovation solutions across 39 countries. His leadership roles at NEORIS and CEMEX were instrumental in driving successful global digital transformation initiatives and establishing data-driven operations. His academic background includes a degree in Telecommunications Engineering, an MBA from IESE, and a degree in Philosophy.

José joined FutureLife as Group Chief Medical Officer on 12 January 2026. A Mexican physician based in Madrid, José brings extensive experience in reproductive medicine and a sophisticated international perspective. Having had the opportunity to learn in some of Europe’s most prestigious fertility programs, he has built a robust global network and a reputation for excellence.  Before joining FutureLife, José founded and led his own clinical group as Medical Director for over 5 years. His unique background—a blend of deep clinical heritage rooted in the origins of IVF in Mexico and a pan-European outlook shaped by his Dutch ancestry—allows him to combine clinical credibility with sharp commercial and operational insight.  In partnership with FutureLife’s medical leadership, José focuses on advancing clinical outcomes and ensuring consistently high standards of care across the Group. He plays a central role in fostering collaboration between clinics, championing evidence-led practices, and strengthening a unified medical culture. As a key representative of FutureLife in leading international forums, José helps shape the Group’s clinical direction as it continues its global expansion.

In 2018, Dr. Štěpán Machač, PhD. joined FutureLife as the Chief Medical Officer. Previously, he held significant roles focusing on reproductive medicine. Graduating from Palacký University of Medicine in Olomouc, he also holds a PhD focusing on Inherited Thrombophilia related to severe OHSS. His career started at the Gynaecology and Obstetrics Clinic at Palacký University Olomouc from 1995 to 2003, where he began focusing on infertility treatment. Prior to his role at FutureLife, between 2006 and 2014, Dr. Machač was the lead IVF doctor for international patients at Reprofit International Clinic. Since 2014, he has overseen the IVF Clinic in Olomouc. Additionally, since 2020, Dr. Machač has been the Chairman of Section of Assisted Reproduction at the Czech Medical Society. He is also an author, writing ad co-writing over 30 lectures and 40 professional articles on assisted reproduction, ovarian hyperstimulation syndrome, and gamma donation.

Nihat joined FutureLife as Group Chief Operating Officer, bringing more than 25 years of experience in FMCG, retail, and multi-site consumer-facing operations across Turkey and the DACH region, with a focus on scaling complex networks in high-growth environments. Prior to FutureLife, Nihat served as Managing Director of GrandVision Germany and Austria, part of EssilorLuxottica, leading one of Europe’s largest optical care platforms across more than 1,000 locations and a workforce of over 6,000. Before that, as CEO of Atasun Optik in Turkey, he delivered double-digit growth for five consecutive years and increased market share from 12% to over 20%. Across both roles, he became known for high performance standards and a genuine ability to earn trust and commitment across diverse teams and cultures. At FutureLife, Nihat is responsible for further developing the Group’s operating model, supporting clinics in delivering high-quality patient care and enabling consistent operational performance across markets.

Yvonne Hignell joined FutureLife in July 2024 and most recently served as Chief Operating Officer. In this role, she played a key part in supporting the Group’s growth and bringing greater structure and discipline to operations across markets. As FutureLife enters its next phase, with a stronger focus on clinic integration and scaling a consistent operating model, Yvonne transitions into the role of Group Director, Clinic Integration & Operating Model. She will focus on driving integration across clinics, supporting the rollout of the target operating model, and ensuring alignment as the Group continues to grow. Yvonne brings extensive experience from senior leadership roles in multi-site healthcare organisations. Prior to joining FutureLife, she served as Chief Operating Officer at Cera Care, where she supported operational scaling and integration, and as Chief of Staff at Linnaeus (a Mars company), focusing on strategic transformation and operating model development. Earlier in her career, she led Bluebird Care as Managing Director, delivering improved performance and growth across the network.